Michael Weickert

Emerald Hills, California, United States
Current CEO of Pacylex Pharmaceuticals, Dr. Weickert, has been in biotech and pharmaceuticals for over 26 years, as CEO of illumiSonics, Sonescence, and SEA Medical Systems, CBO of Strategent Life Sciences, Corium, and Therashock, COO of Ohm Oncology, VP of development at SciDose and Auspex, and Senior Program Executive or Manager at Nektar and Ligand. Key roles included raising capital, establishing and maintaining business partnerships, building teams, and developing new pharmaceutical products. He raised Seed through Series C capital and established partnerships worth more than $175 Million.
Speaking In
3:15 PM - 3:30 PM
Tuesday, October 22
Pacylex is a Canadian oncology company exploiting a new discovery in cancer biology which may…